Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients

Linnan Zhu,Penghui Yang,Yingze Zhao,Zhenkun Zhuang,Zhifeng Wang,Rui Song,Jie Zhang,Chuanyu Liu,Qianqian Gao,Qumiao Xu,Xiaoyu Wei,Hai-Xi Sun,Beiwei Ye,Yanan Wu,Ning Zhang,Guanglin Lei,Lingxiang Yu,Jin Yan,Guanghao Diao,Fanping Meng,Changqing Bai,Panyong Mao,Yeya Yu,Mingyue Wang,Yue Yuan,Qiuting Deng,Ziyi Li,Yunting Huang,Guohai Hu,Yang Liu,Xiaoqian Wang,Ziqian Xu,Peipei Liu,Yuhai Bi,Yi Shi,Shaogeng Zhang,Zhihai Chen,Jian Wang,Xun Xu,Guizhen Wu,Fu-Sheng Wang,George F Gao,Longqi Liu,William J Liu,George F. Gao,William J. Liu

DOI: https://doi.org/10.1016/j.immuni.2020.07.009

IF: 32.4

2020-09-01

Immunity

Abstract:The coronavirus disease 2019 (COVID-19) pandemic poses a current world-wide public health threat. However, little is known about its hallmarks compared to other infectious diseases. Here, we report the single-cell transcriptional landscape of longitudinally collected peripheral blood mononuclear cells (PBMCs) in both COVID-19- and influenza A virus (IAV)-infected patients. We observed increase of plasma cells in both COVID-19 and IAV patients and XIAP associated factor 1 (XAF1)-, tumor necrosis factor (TNF)-, and FAS-induced T cell apoptosis in COVID-19 patients. Further analyses revealed distinct signaling pathways activated in COVID-19 (STAT1 and IRF3) versus IAV (STAT3 and NFκB) patients and substantial differences in the expression of key factors. These factors include relatively increase of interleukin (<em>IL</em>)<em>6R</em> and <em>IL6ST</em> expression in COVID-19 patients but similarly increased IL-6 concentrations compared to IAV patients, supporting the clinical observations of increased proinflammatory cytokines in COVID-19 patients. Thus, we provide the landscape of PBMCs and unveil distinct immune response pathways in COVID-19 and IAV patients.

immunology